Ann: HER-Vaxx induced antibodies correlated with tumour reduction, page-37

This is clearly working AND has demonstrated why ... a clear link ...

• HER-Vaxx induced antibodies correlated with tumour reduction (p=0.001)

If Big Pharma had doubts around 'why', then this additional data should help. BP can be notoriously cautious
so this is another piece of the puzzle that has been laid out for them. The B-Cell platform needed to be proved
and it seems IMU is well on its way to doing this now. Who knows ... we still may see a HER-VAXX deal yet.

Slow and steady. No fails yet. Huge safety profile .... and it clearly works over current SoC.
HER-VAXX may just have become a little more attractive. Let's see.